EUVIMEDEUVIMED entdecken
Vergleichsstudie

Integrated [18F]FAPI-42 PET/MR improves diagnostic accuracy in breast cancer: comparison with simultaneously acquired breast MRI

Peng Hou, Jie Lv, Weige Tan, Shaonan Zhong, Sihao Liang, Youcai Li, Miao Ke, Penghao Chen, Ruiyue Zhao, Huizhen Zhong, Qiao Zou, Xigang Ye und 2 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-01 · 53 (2) · 1004-1014

DOI: 10.1007/s00259-025-07460-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 13.08.2025. Verfasst von Peng Hou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan 2…. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Positron-Emission Tomography, Multimodal Imaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: the Science and Technology Projects in Guangzhou, China, the Guangdong regional joint fund, the Guangdong Provincial Medical Science and Technology Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study assessed the diagnostic efficacy of fluorine-18-labeled fibroblast activation protein inhibitor 42 ([18F]FAPI-42) PET/MR versus simultaneously acquired breast MRI in identifying primary breast lesions and axillary lymph node metastases. METHODS: A prospective study enrolled 64 women with BI-RADS 4 or 5 lesions identified through mammography or ultrasound. All participants underwent contrast-enhanced [18F]FAPI PET/MRI scans of the breast. Histology and imaging follow-up (median 11.5 months) were used as the gold standard. Primary lesions and lymph nodes were assessed using three imaging modalities: breast MRI, qualitative/quantitative [18F]FAPI PET, and integrated [18F]FAPI PET/MR. Quantitative PET parameters comprised the maximum standardized uptake value (SUVmax) and the tumor-to-background ratio (TBR). Receiver operating characteristic analysis assessed diagnostic performance, while net reclassification improvement (NRI) evaluated the diagnostic enhancement of PET/MR compared to breast MRI. RESULTS: The study included 114 breast lesions (89 malignant, 25 benign) and 114 lymph node groups (82 malignant, 32 benign). In detecting primary breast lesions, the quantitative PET/MR based on TBR (PET/MR-TBR) demonstrated superior specificity over breast MRI (96% vs. 68%, P = 0.016), corresponding to a marked reduction in false positive rate from 32% (8/25) to 4.0% (1/25; P = 0.027), while maintaining comparable sensitivity (94% vs. 97%, P = 1.00). For BI-RADS 3/4 lesions on breast MRI, PET/MR-TBR achieved an AUC of 0.90, with a significant NRI of 90.5% (P = 0.018) for BI-RADS 4 lesions. For breast lesions smaller than 10 mm, PET/MR-TBR increased specificity to 94% versus 75% for breast MRI (P > 0.05). For axillary lymph node evaluation, the quantitative PET/MR based on SUVmax (PET/MR-SUVmax) showed improved sensitivity (95% vs. 62%, P < 0.001) and a nonsignificant decrease in specificity (94% vs. 97%, P = 1.00) compared with breast MRI. CONCLUSION: [18F]FAPI PET/MR significantly improves diagnostic accuracy over breast MRI, particularly in reducing false positives and improving the detection of axillary lymph node metastases. This modality holds potential for refining breast cancer diagnostics, especially in challenging BI-RADS 4 lesions and improving more accurate staging for smaller lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMagnetic Resonance ImagingPositron-Emission TomographyMultimodal ImagingHumansFemaleMiddle AgedAdultAgedLymphatic MetastasisProspective Studies

Stichwörter der Autor:innen

Breast cancerDiagnostic accuracyFibroblast activation protein inhibitorMolecular imagingPET/MR

Autor:innen und Institutionen

  • Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan 2nd Road, Guangzhou, 510080, China.
  • Department of Nuclear Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510010, China.
  • Department of Breast Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510010, China.
  • Department of Radiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510010, China.
  • Department of Breast Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510010, China. 39357932@qq.com.
  • Department of Nuclear Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510010, China. 71lu@163.com.

Förderung

  • the Science and Technology Projects in Guangzhou, China
  • the Guangdong regional joint fund
  • the Guangdong Provincial Medical Science and Technology Research Fund

Zitieren

APA

Hou, P., Lv, J., Tan, W., Zhong, S., Liang, S., Li, Y., Ke, M., Chen, P., Zhao, R., Zhong, H., Zou, Q., Ye, X., Wang, X., & Liang, C. (2026). Integrated [18F]FAPI-42 PET/MR improves diagnostic accuracy in breast cancer: comparison with simultaneously acquired breast MRI. European Journal of Nuclear Medicine and Molecular Imaging, 53(2), 1004-1014. https://doi.org/10.1007/s00259-025-07460-3

Vancouver

Hou P, Lv J, Tan W, Zhong S, Liang S, Li Y, et al. Integrated [18F]FAPI-42 PET/MR improves diagnostic accuracy in breast cancer: comparison with simultaneously acquired breast MRI. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(2):1004-1014. doi:10.1007/s00259-025-07460-3

BibTeX
@article{Hou2026,
  author = {Hou, Peng and Lv, Jie and Tan, Weige and Zhong, Shaonan and Liang, Sihao and Li, Youcai and Ke, Miao and Chen, Penghao and Zhao, Ruiyue and Zhong, Huizhen and Zou, Qiao and Ye, Xigang and Wang, Xinlu and Liang, Changhong},
  title = {Integrated [18F]FAPI-42 PET/MR improves diagnostic accuracy in breast cancer: comparison with simultaneously acquired breast MRI},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {2},
  pages = {1004--1014},
  doi = {10.1007/s00259-025-07460-3}
}
Kostenlos starten →